StockData

Enova International vs Regional Management

ENVA and RM side by side, both in personal credit institutions. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ENVA and RM compare

Enova International is the larger company, worth 13 times as much as Regional Management ($4.1B against $311M).

On earnings, Regional Management is cheaper: it trades at 7.0× trailing earnings, against 11.5× for Enova International.

Enova International grew revenue faster over the last twelve months (20.1% versus 8.4% for Regional Management).

Enova International keeps more of each dollar of sales as profit, with a net margin of 10.5% compared with 7.0% at Regional Management.

Regional Management pays a dividend yielding 3.5%; Enova International does not pay one.

Regional Management scores higher on the StockData Score (14 against 10 for Enova International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricENVARM
Size and price
Market cap$4.1B$311M
Share price$167.01$34.74
Change, 1 year31.2%−8.2%
Change, 5 years322%−43.5%
Beta (5Y)1.371.05
Employees1,8362,112
StockData Score
Total score1014 (better)
Valuation score26 (better)
Growth score5 (better)1
Performance score3 (better)1
Health score04 (better)
Dividend score02 (better)
Valuation
P/E11.5×7.0× (better)
P/S1.1×0.5× (better)
P/B2.6×0.8× (better)
EV/EBITDA4.3×3.8× (better)
P/FCF2.0×1.0× (better)
PEG0.50–
FCF yield49.1%103% (better)
Fair value$223.65$46.60
Margin of safety25.3%25.5% (better)
Growth
Revenue growth (TTM)20.1% (better)8.4%
Revenue growth, 5Y average23.8% (better)11.5%
Net income growth (TTM)30.5% (better)14.9%
EPS growth (TTM)33.4% (better)19.6%
EPS growth, 5Y average−0.31%13.1% (better)
Profitability
Gross margin60.6%–
Operating margin24.0%–
Net margin10.5% (better)7.0%
FCF margin54.9% (better)46.7%
Return on equity26.8% (better)12.6%
Return on invested capital50.4%–
Financial health
Debt / equity–0.00
Interest coverage2.3×–
Altman Z-score1.67 (better)0.69
Piotroski F-score8 (better)5
Dividends and buybacks
Dividend yield–3.5%
Years of dividend growth–0
Dividend growth, 5Y average–43.1%
Buyback yield3.5%9.7% (better)
Shareholder yield3.5%13.2% (better)
Ownership
Held by institutions96.4%91.5%
Held by insiders5.4%17.9%
Insider net buying, 12 months−$72.4M−$12.3M (better)
Short interest, % of float7.3%5.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.